Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanton L Gerson

Showing results (31-40 of 122) with videos related to

Pageof 13
Sort By:
Molecular Cancer Research : MCR|November 10, 2017
Loss of Uracil DNA Glycosylase Selectively Resensitizes p53-Mutant and -Deficient Cells to 5-FdUYan Yan, Yulan Qing, John J Pink, et al.
Cancer Research|May 31, 2002
Chemotherapy-induced O(6)-benzylguanine-resistant alkyltransferase mutations in mismatch-deficient colon cancerLili Liu, Stuart Schwartz, Brian M Davis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 15, 2004
Limited lentiviral transgene expression with increasing copy number in an MGMT selection model: lack of copy number selection by drug treatmentSteven P Zielske, Karen T Lingas, Yan Li, et al.
Trends in Cancer|November 10, 2017
New Opportunities and Challenges to Defeat Cancer Stem CellsErika K Ramos, Andrew D Hoffmann, Stanton L Gerson, et al.
Journal of Hematotherapy & Stem Cell Research|September 11, 2003
Drug selection of mutant methylguanine methyltransferase from different oncoretroviral backbones results in multilineage hematopoietic transgene expression in primary and secondary recipientsBrian M Davis, Jane S Reese, Karen Lingas, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 30, 2012
Development and validation of an LC-MS/MS method for pharmacokinetic study of methoxyamine in phase I clinical trialShuming Yang, Panayiotis Savvides, Lili Liu, et al.
Chemmedchem|November 9, 2012
Two-photon fluorescent imaging of myelination in the spinal cordAllison G Condie, Stanton L Gerson, Robert H Miller, et al.
Radiation Research|September 30, 2017
Long-Term Deficits in Behavior Performances Caused by Low- and High-Linear Energy Transfer RadiationRutulkumar Patel, Hiroyuki Arakawa, Tomas Radivoyevitch, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 5, 2003
Myeloablation is not required to select and maintain expression of the drug-resistance gene, mutant MGMT, in primary and secondary recipientsJanice E Bowman, Jane S Reese, Karen T Lingas, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 10, 2011
Imaging stem cell-derived persistent foci after in vivo selection of lentiviral MGMT-P140K transduced murine bone marrow cellsYuan Lin, Perrin Cheung, Justin C Roth, et al.
Pageof 13

Showing results (31-40 of 122) with videos related to

Sort By:
Pageof 13
Molecular Cancer Research : MCR|November 10, 2017
Loss of Uracil DNA Glycosylase Selectively Resensitizes p53-Mutant and -Deficient Cells to 5-FdUYan Yan, Yulan Qing, John J Pink, et al.
Cancer Research|May 31, 2002
Chemotherapy-induced O(6)-benzylguanine-resistant alkyltransferase mutations in mismatch-deficient colon cancerLili Liu, Stuart Schwartz, Brian M Davis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 15, 2004
Limited lentiviral transgene expression with increasing copy number in an MGMT selection model: lack of copy number selection by drug treatmentSteven P Zielske, Karen T Lingas, Yan Li, et al.
Trends in Cancer|November 10, 2017
New Opportunities and Challenges to Defeat Cancer Stem CellsErika K Ramos, Andrew D Hoffmann, Stanton L Gerson, et al.
Journal of Hematotherapy & Stem Cell Research|September 11, 2003
Drug selection of mutant methylguanine methyltransferase from different oncoretroviral backbones results in multilineage hematopoietic transgene expression in primary and secondary recipientsBrian M Davis, Jane S Reese, Karen Lingas, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 30, 2012
Development and validation of an LC-MS/MS method for pharmacokinetic study of methoxyamine in phase I clinical trialShuming Yang, Panayiotis Savvides, Lili Liu, et al.
Chemmedchem|November 9, 2012
Two-photon fluorescent imaging of myelination in the spinal cordAllison G Condie, Stanton L Gerson, Robert H Miller, et al.
Radiation Research|September 30, 2017
Long-Term Deficits in Behavior Performances Caused by Low- and High-Linear Energy Transfer RadiationRutulkumar Patel, Hiroyuki Arakawa, Tomas Radivoyevitch, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 5, 2003
Myeloablation is not required to select and maintain expression of the drug-resistance gene, mutant MGMT, in primary and secondary recipientsJanice E Bowman, Jane S Reese, Karen T Lingas, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 10, 2011
Imaging stem cell-derived persistent foci after in vivo selection of lentiviral MGMT-P140K transduced murine bone marrow cellsYuan Lin, Perrin Cheung, Justin C Roth, et al.
Pageof 13